Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
Second malignancies following treatment for Hodgkin's disease: a Greek experience. [electronic resource] by
- Economopoulos, T
- Stathakis, N
- Alexopoulos, C
- Pavlidis, N
- Constantinidou, M
- Briassoulis, E
- Papageorgiou, E
- Dervenoulas, J
- Pappa, V
- Vaslamatzis, M
Producer: 19941110
In:
Haematologica vol. 79
Availability: No items available.
|
|
|
5.
|
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial. [electronic resource] by
- Alexopoulos, K
- Kouroussis, C
- Androulakis, N
- Papadakis, E
- Vaslamatzis, M
- Kakolyris, S
- Samelis, G
- Patila, E
- Vossos, A
- Samantas, E
- Georgoulias, V
Producer: 19990204
In:
Cancer chemotherapy and pharmacology vol. 43
Availability: No items available.
|
|
|
6.
|
Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG). [electronic resource] by
- Matikas, A
- Kentepozidis, Ν
- Ardavanis, A
- Vaslamatzis, M
- Polyzos, A
- Emmanouilides, Ch
- Katsaounis, P
- Koinis, F
- Xynogalos, S
- Christopoulou, A
- Ziras, N
- Tegos, Th
- Prinarakis, E
- Hatzidaki, D
- Georgoulias, V
- Kotsakis, A
Producer: 20170606
In:
Cancer chemotherapy and pharmacology vol. 78
Availability: No items available.
|
|
|
7.
|
Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). [electronic resource] by
- Kotsakis, A
- Kentepozidis, N
- Emmanouilidis, Ch
- Polyzos, A
- Agelidou, A
- Vaslamatzis, M
- Chandrinos, V
- Agelaki, S
- Vamvakas, L
- Kalbakis, K
- Katsaounis, P
- Stoltidis, D
- Nintos, G
- Hatzidaki, D
- Vetsika, E K
- Mavroudis, D
- Georgoulias, V
Producer: 20151201
In:
Lung cancer (Amsterdam, Netherlands) vol. 88
Availability: No items available.
|
|
|
8.
|
Chemotherapy improves low performance status lung cancer patients. [electronic resource] by
- Sculier, J P
- Lafitte, J J
- Paesmans, M
- Lecomte, J
- Alexopoulos, C G
- Van Cutsem, O
- Giner, V
- Efremidis, A
- Berchier, M C
- Collon, T
- Meert, A P
- Scherpereel, A
- Ninane, V
- Koumakis, G
- Vaslamatzis, M M
- Leclercq, N
- Berghmans, T
Producer: 20080227
In:
The European respiratory journal vol. 30
Availability: No items available.
|
|
|
9.
|
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project. [electronic resource] by
- Souglakos, J
- Boukovinas, I
- Kakolyris, S
- Xynogalos, S
- Ziras, N
- Athanasiadis, A
- Androulakis, N
- Christopoulou, A
- Vaslamatzis, M
- Ardavanis, A
- Emmanouilides, C
- Bompolaki, I
- Kourousis, C
- Makrantonakis, P
- Christofyllakis, C
- Athanasiadis, E
- Kentepozidis, N
- Karampeazis, A
- Katopodi, U
- Anagnosopoulos, A
- Papadopoulos, G
- Prinarakis, E
- Kalisperi, A
- Mavroudis, D
- Georgoulias, V
Producer: 20200609
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 30
Availability: No items available.
|